SynthesisThe Cochrane database of systematic reviews2019

Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.

Sheila A Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.